H.R. 1902, The Protecting Consumer Access to Generic Drugs Act of 2007 (4 wiki edits)
- This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
H.R. 1902 would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.